{"id":"W2273249389","doi":"10.1111/imr.12409","title":"Discovery and bio‐optimization of human antibody therapeutics using the XenoMouse<sup>®</sup> transgenic mouse platform","year":2016,"lang":"en","type":"review","venue":"Immunological Reviews","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Amgen (Canada)","funders":"Amgen","keywords":"Panitumumab; Monoclonal antibody; Antibody; Drug discovery; Transgene; Computational biology; Genetically modified mouse; Biology; Immunology; Cancer research; Bioinformatics; Cetuximab; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008139982,0.0005940669,0.002901066,0.0001614174,0.0002468457,0.00006071347,0.000472788,0.0004716305,0.0002161485],"category_scores_gemma":[0.0001256212,0.0002376988,0.001024741,0.0003494381,0.0007774775,0.0001424411,0.0002192904,0.0007657633,0.00003531696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009155568,"about_ca_system_score_gemma":0.0001581198,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002502571,"about_ca_topic_score_gemma":7.450417e-7,"domain_scores_codex":[0.9967592,0.0004703005,0.00141435,0.0004976185,0.0003700203,0.00048852],"domain_scores_gemma":[0.998121,0.000433057,0.000560338,0.0007090626,0.00009029236,0.00008619846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000684641,0.000146565,0.00001119104,0.009231203,0.0004733155,0.000006810118,0.0000634256,0.000002415349,0.001008389,0.0004864408,0.00001195533,0.9884898],"study_design_scores_gemma":[0.0003521418,0.0005004972,0.000006553541,0.01394407,0.001037884,0.0001139598,0.00001874438,0.00006665903,0.00005745738,0.00004404601,0.9835466,0.0003113944],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001246226,0.9952944,0.0007152516,0.0001176317,0.00003839646,0.002185528,0.0001022092,0.00002660296,0.0002737856],"genre_scores_gemma":[0.00006188782,0.9970994,0.0004456527,0.0001059508,0.0001521131,0.00005719647,0.0001992031,0.00005476962,0.001823855],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9881784,"threshold_uncertainty_score":0.9693076,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.209739604644202,"score_gpt":0.4397247322930682,"score_spread":0.2299851276488662,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}